| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |